Skip to main content

Table 2 Colonic mucosal gene expression among different groups

From: Gene expression analysis in NSAID-induced rat small intestinal disease model with the intervention of berberine by the liquid chip technology

  Control group Model group Intervention group
HTR4 0.073 ± 0.030 0.383 ± 0.212a 0.228 ± 0.074b
HTR1a 0.137 ± 0.055 0.608 ± 0.252a 0.534 ± 0.353
F2RL3 0.294 ± 0.091 1.523 ± 0.502a 0.990 ± 0.295b
NOS1 1.254 ± 0.340 0.649 ± 0.289a 1.127 ± 0.315b
CALCA 0.271 ± 0.123 0.586 ± 0.314a 0.578 ± 0.319
NPY 0.243 ± 0.083 1.126 ± 0.354a 0.634 ± 0.262b
CRHR2 0.201 ± 0.078 0.836 ± 0.333a 0.538 ± 0.334b
IL1b 0.006 ± 0.001 0.082 ± 0.060a 0.044 ± 0.010b
P2RX3 0.147 ± 0.059 0.415 ± 0.272a 0.366 ± 0.179
NOS2 0.224 ± 0.072 0.517 ± 0.365 0.778 ± 0.443
TPH1 0.033 ± 0.012 0.275 ± 0.231a 0.299 ± 0.010
CRHR1 0.005 ± 0.002 0.028 ± 0.033 0.006 ± 0.002
HMOX1 0.495 ± 0.127 1.616 ± 0.624a 1.727 ± 0.449
TRPV1 0.053 ± 0.017 0.156 ± 0.087a 0.179 ± 0.109
VIP 0.594 ± 0.185 1.110 ± 0.406a 0.438 ± 0.167b
F2RL1 0.312 ± 0.047 1.451 ± 0.372a 1.483 ± 0.460
TGFB1 0.210 ± 0.050 0.205 ± 0.099 0.188 ± 0.050
HTR3a 0.204 ± 0.059 0.162 ± 0.081 0.136 ± 0.062
SLC6a4 0.249 ± 0.086 1.565 ± 0.553a 1.416 ± 0.540
TFF2 0.031 ± 0.011 0.114 ± 0.067a 0.140 ± 0.088
AQP8 0.227 ± 0.109 0.856 ± 0.253a 0.414 ± 0.201b
  1. a P < 0.05 compared with control group; b P < 0.05 compared with model group